[go: up one dir, main page]

WO2000065090A3 - The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders - Google Patents

The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders Download PDF

Info

Publication number
WO2000065090A3
WO2000065090A3 PCT/US2000/010644 US0010644W WO0065090A3 WO 2000065090 A3 WO2000065090 A3 WO 2000065090A3 US 0010644 W US0010644 W US 0010644W WO 0065090 A3 WO0065090 A3 WO 0065090A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
gene sequence
human obesity
diabetic disorders
receptor
Prior art date
Application number
PCT/US2000/010644
Other languages
French (fr)
Other versions
WO2000065090A2 (en
Inventor
Si Lok
Theodore E Whitmore
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU46498/00A priority Critical patent/AU4649800A/en
Publication of WO2000065090A2 publication Critical patent/WO2000065090A2/en
Publication of WO2000065090A3 publication Critical patent/WO2000065090A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides methods for identifying abnormalities in human chromosome 1q that are linked to defects in glucose metabolism. The present invention also provides methods for identifying polymorphisms in an insulin receptor-related receptor gene that resides on chromosome 1q21-q24, and more specifically, 1q21-q23, a locus linked with a heritable form of Type II diabetes.
PCT/US2000/010644 1999-04-22 2000-04-19 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders WO2000065090A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46498/00A AU4649800A (en) 1999-04-22 2000-04-19 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29690699A 1999-04-22 1999-04-22
US09/296,906 1999-04-22
US33797699A 1999-06-22 1999-06-22
US09/337,976 1999-06-22

Publications (2)

Publication Number Publication Date
WO2000065090A2 WO2000065090A2 (en) 2000-11-02
WO2000065090A3 true WO2000065090A3 (en) 2001-10-25

Family

ID=26969879

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010644 WO2000065090A2 (en) 1999-04-22 2000-04-19 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders

Country Status (2)

Country Link
AU (1) AU4649800A (en)
WO (1) WO2000065090A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2151502A1 (en) * 2008-07-30 2010-02-10 Lohmann Tierzucht GmbH Genetic variations associated with feather pecking behaviour in avians
CN116183930A (en) * 2022-12-29 2023-05-30 陕西脉元生物科技有限公司 Application of anti-INSRR antibody in the preparation of products for detecting and/or diagnosing nervous system-related diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023591A2 (en) * 1998-10-21 2000-04-27 Zymogenetics, Inc. Secreted protein zsig49

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023591A2 (en) * 1998-10-21 2000-04-27 Zymogenetics, Inc. Secreted protein zsig49

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ELBEIN S C ET AL: "GENOME-WIDE SEARCH FOR TYPE 2 DIABETES SUSCEPTIBILITY GENES IN CAUCASIANS: EVIDENCE FOR A RECESSIVE LOCUS ON CHROMOSOME 1", DIABETES,NEW YORK, NY,US, 13 June 1998 (1998-06-13), pages 1278b, XP000906839, ISSN: 0012-1797 *
ELBEIN S.C. ET AL.: "A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians", DIABETES, vol. 48, no. 5, May 1999 (1999-05-01), pages 1175 - 1182, XP000944793 *
HANSON R L ET AL: "AN AUTOSOMAL GENOMIC SCAN FOR LOCI LINKED TO TYPE II DIABETES MELLITUS AND BODY-MASS INDEX IN PIMA INDIANS", AMERICAN JOURNAL OF HUMAN GENETICS,US,UNIVERSITY OF CHICAGO PRESS, CHICAGO,, vol. 63, no. 4, 1998, pages 1130 - 1138, XP000909507, ISSN: 0002-9297 *
ITOH N. ET AL.: "Two truncated forms of rat insulin receptor-related receptor", J. BIOL. CHEM., vol. 268, no. 24, 25 August 1993 (1993-08-25), pages 17983 - 17986, XP002154781 *
SHIER P. AND WATT V.M.: "Primary structure of a putative receptor for a ligand of the insulin family", J. BIOL. CHEM., vol. 264, no. 25, 5 September 1989 (1989-09-05), pages 14605 - 14608, XP002154780 *
SHIER P. ET AL.: "Localization of the insulin receptor-related receptor gene on human chromosome 1", CYTOGENET CELL GENET, vol. 54, 1990, pages 80 - 81, XP000944567 *
WHITMORE T.E. ET AL.: "The assignment of the human insulin receptor-related receptor gene (INSRR) tp chromosome 1q21-q23 by the use of radiation hybrid mapping", CYTOGENET CELL GENET, vol. 87, no. 1-2, 1999, pages 93 - 94, XP000944566 *

Also Published As

Publication number Publication date
WO2000065090A2 (en) 2000-11-02
AU4649800A (en) 2000-11-10

Similar Documents

Publication Publication Date Title
Pascoe et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic β-cell function
Tan et al. Association of resistin gene 3′-untranslated region+ 62G→ A polymorphism with type 2 diabetes and hypertension in a Chinese population
Park et al. Polymorphisms in the leptin receptor (LEPR)—putative association with obesity and T2DM
WO2006063704A3 (en) Single nucleotide polymorphism (snp) associated to type ii diabetes
Ruegsegger et al. Running from disease: molecular mechanisms associating dopamine and leptin signaling in the brain with physical inactivity, obesity, and type 2 diabetes
WO2003038123A3 (en) Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
Roussel et al. The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus
WO2006004574A3 (en) Method for using gamma cyclodextrin to control blood glucose and insulin secretion
Østergård et al. Influence of the PPAR-γ2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects
Valenti et al. Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance
Dirkali et al. The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction
EP1871894A4 (en) The 1, 5-anhydroglucitol (1, 5-ag) assay and a1c/1. 5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients
WO2000065090A3 (en) The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders
ITMI20002019A0 (en) METHOD FOR TREATMENT OF METABOLIC DISORDERS, PARTICULARLY DIABETES OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES
Mohás et al. A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus
WO2008065544A3 (en) Genetic predictors of risk for type 2 diabetes mellitus
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
WO2003101177A3 (en) Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
Mendoza-Lorenzo et al. The reduction of Calpain-10 expression is associated with risk polymorphisms in obese children
Fischer et al. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts
WO2006063703A3 (en) Single nucleotide polymorphism (snp) associated to type ii diabetes
Buraczynska et al. Leu72Met polymorphism in ghrelin gene: a potential risk factor for hypertension in type 2 diabetes patients
Dorsey-Trevino et al. Association of GLP1R polymorphisms with the incretin response
WO2004042358A3 (en) HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
WO2002074989A3 (en) Disease associated polymorphism in the ctla-4 locus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP